Post Profile






Related Posts


NYU Dentistry awarded $1.9 million from NIDDK for osteoporosis drug research and development

Academics / Chemistry : EurekAlert: Chemistry

(New York University) The federally funded grant will support bench research aimed at understanding how the protein hormone, parathyroid hormone-a related protein-and a drug analog that mimics the protein called abaloparatide, inter...

Drugs That Affect Serotonin Signaling May Combat Bone Loss

Health : Medical News Today

Scientists have long known that calcium leaches from the bones both during lactation and in certain types of cancer. The driver behind these phenomena is a molecule called parathyroid hormone related protein (PTHrP), which is secret...

Immune studies suggest remedies for parathyroid hormone-driven bone loss

Academics / General Science : ScienceDaily: Science Society

A common cause of bone loss is an overactive parathyroid gland, which doctors usually treat with surgery. New research on how excess parathyroid hormone affects immune cells suggests that doctors could repurpose existing drugs to tr...

NYU College of Dentistry's Dr. Nicola Partridge Awarded $1.9 M to Further Osteoporosis Drug Research and Development

Health : Newswise Medical News

The federally funded grant will support bench research aimed at understanding how the protein hormone, parathyroid hormone-a related protein-and a drug analog that mimics the protein called abaloparatide, interact in the surface of ...

Study finds evidence that a protein, MCP-1, may determine bone loss responses to parathyroid hormone

Health : EurekAlert: Health

(New York University) In a new study published in November in Scientific Reports, NYU Dentistry researchers investigating the catabolic effect of parathyroid hormone (PTH) in hyperparathyroidism (HPT) showed, for the first time, tha...

Comments


Copyright © 2016 Regator, LLC